Allen Institute for Artificial Intelligence logo

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 4 months ago

Possible Interaction: Cyproterone and Recombinant Luteinizing Hormone

Research Papers that Mention the Interaction

In the second study cyproterone acetate produced a reduction in plasma testosterone, LH and follicle-stimulating hormone (FSH).
The Journal of endocrinology  •  1975  |  View Paper
Administration of cyproterone acetate in daily doses of 5 10 and 20 mg produces significant decrease in sperm count associated with decrease in blood concentrations of testosterone and luteinizing hormone ( LH).
Akusherstvo i ginekologiia  •  1980  |  View Paper
cyproterone acetate induced marked reduction in the size and consistency of tumor, while it caused moderate suppression of serum luteinizing hormone , follicle-stimulating hormone and testosterone levels.
The Journal of urology  •  1980  |  View Paper
CPA significantly suppressed LH (mean suppression, 39%), follicle stimulating hormone (66%), T (73%), DT (51%), 17-P (59%), and A (30%) in all 10 subjects, but it did not affect the circadian pattern.
Contraception  •  1979  |  View Paper
Serum LH concentrations were increased by both doses of cyproterone , 22% by 2 mg and 40% by 10 mg; serum FSH was unchanged.
Endocrinology  •  1972  |  View Paper
Our results also show that a combination of CPA and Lh inhibits phosphorylation of extracellular signal-regulated kinase (Erk), kinases that are associated with oocyte maturation in many species.
Aquatic toxicology  •  2015  |  View Paper
Cyproterone acetate may have blocked hypothalamic LHRH stimulation of pituitary LH gonadotrophs.
Archives of andrology  •  1982  |  View Paper